Medigard Ltd (MGZ)
20mins delayed
Movement
1 Year Return
Medigard Ltd Chart
| Share price | |
| Last | |
| Change | |
| Volume | |
| Turnover | |
| Market Cap | $3.45 million |
| Today's Movement | |
| Prev. Close | |
| Open | |
| Day Range | - |
| VWAP | |
| Historical Stats | |
| 52w Range | - |
| 4w Avg Volume | |
| 4w Avg Turnover | |
| (delayed) | |
MGZ Statistics
19 January
2,328 / 2,256
ASX Size Rank
1yr Return
vs Sector (1yr)
-11.64%
vs ASX 200 (1yr)
+4.76%
$3.45 million
Market Cap
Share Issue
172.47 million
All Ords (%)
N/A
Short Sold
0%
Current Fundamentals
19 January
11.8
PE Ratio
EPS ($)
0.002
Earnings Yield
8.50%
NTA ($)
-
0.00%
Dividend Yield
DPS ($)
-
Gross Div. Yield
-
Gross DPS ($)
-
Company Overview
Medigard Limited (MGZ) is involved in medical technologies innovation and research and development, acquisition of a licence to utilise intellectual property to advance the KT009 project to treat degenerative disk disease with an injectable product, progressing and maintenance of patents and conduct of our licence arrangement and liaison with Shanghai Sol-Millennium MedicalProducts Co., Ltd on the Blood Collection Device and the Flash Back Needle.
Former Names
--
Upcoming Calendar
| 26 Feb 2021 | Report (Interim) |
| 30 Aug 2021 | Report (Prelim) |
Dividend History
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| No dividends paid in the last 5 years | ||||
See Upcoming Dividends for all ASX companies.
Announcements
| Date | Heading | Pages | File Size | Time |
|---|---|---|---|---|
Announcements provided by
Broker Consensus
The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.
MGZ is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.
Directors & Management
| Name | Title | Since | Bio |
|---|---|---|---|
| Dr Ian Edward Dixon | Executive Director | Nov 2017 |
|
| Mr Donald Julian Channer | Non-Executive Director | Oct 1999 |
|
| Ms Patricia Mary Boero | Chief Financial Officer, Alternate Director - Donald Channer, Company Secretary | Mar 2006 |
|
| Mr Craig Duncan Cameron | Non-Executive Director | Nov 2016 |
|
| Dr Christopher Jan Bishop | Non-Executive Director, Non-Executive Chairman | Sep 2008 |
|
Director Transactions
MGZ directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
| Date | Director | Type | Amount | Price | Value | Notes |
|---|---|---|---|---|---|---|
| 09/12/19 | Ian Dixon | Issued | 14,608,569 | $0.014 | $204,519 | Issue of securities. |
| 09/12/19 | Donald Channer | Issued | 7,142,857 | $0.014 | $100,000 | Issue of securities. |
| 09/12/19 | Craig Cameron | Issued | 1,454,856 | $0.014 | $20,367 | Issue of securities. |
| 09/12/19 | Christopher Bishop | Issued | 1,818,570 | $0.014 | $25,459 | Issue of securities. |
| 31/07/18 | Ian Dixon | Issued | 80,000,000 | $0.016 | $1,280,000 | Issue of options. |
| 31/07/18 | Ian Dixon | Issued | 1,428,571 | $0.018 | $25,000 | Placement. |
| 31/07/18 | Donald Channer | Issued | 3,428,571 | $0.018 | $60,000 | Placement. |
| 31/07/18 | Patricia Boero | Issued | 1,428,571 | $0.018 | $25,000 | Placement. |
| 31/07/18 | Christopher Bishop | Issued | 3,714,285 | $0.018 | $65,000 | Placement. |
| 06/12/17 | Patricia Boero | Buy | +3,500,000 | $0.024 | $85,050 | Director remuneration. |
| 06/12/17 | Craig Cameron | Buy | +1,000,000 | $0.024 | $24,300 | Director remuneration. |
| 06/12/17 | Christopher Bishop | Buy | +1,500,000 | $0.024 | $36,450 | Director remuneration. |
| 24/05/13 | Peter Clark | Sell | -200,000 | $0.035 | ($7,000) | |
| 11/04/13 | Peter Clark | Sell | -200,000 | $0.019 | ($3,800) | |
| 26/03/13 | Peter Clark | Sell | -600,000 | $0.015 | ($9,000) |
Shareholder Distribution
| Holding Size | 1 - 1,000 | 1,001 - 5,000 | 5,001 - 10,000 | 10,001 - 100,000 | 100,001 and over | Total Shareholders |
|---|---|---|---|---|---|---|
| No. of Shareholders | 28 | 58 | 124 | 321 | 135 | 666 |
Top 20 Shareholders
| Name | Shares | Capital |
|---|---|---|
| Donald Julian Channer | 30,546,263 | 22.58% |
| Robin J Bishop & Christopher J Bishop |
5,214,285 | 3.85% |
| Sun Sea Pty Ltd | 4,566,004 | 3.37% |
| Mr Warner Lamb & Mrs Aily Lamb |
4,200,000 | 3.10% |
| Ganbaru Pty Ltd |
3,767,004 | 2.78% |
| Allop Pty Ltd |
3,607,143 | 2.67% |
| Woodwright Services Pty Ltd |
3,500,000 | 2.59% |
| Mr Robert William Higham & Mrs Rhonda Catherine Higham |
3,200,000 | 2.37% |
| Montezuma Pty Ltd |
2,857,143 | 2.11% |
| Mr Richard Lutkajtis |
2,127,734 | 1.57% |
| RHC Superfund Pty Ltd |
1,553,575 | 1.15% |
| Mr Robert Krakowiak | 1,500,000 | 1.11% |
| 3DI Design Pty Ltd |
1,500,000 | 1.11% |
| Helium Management Pty Ltd |
1,428,571 | 1.06% |
| Joanne Hook | 1,428,571 | 1.06% |
| Mrs Patricia Mary Boero & Mr John Anthony Boero |
1,428,571 | 1.06% |
| Mr Matthew Simon Anthony Kelly | 1,400,000 | 1.03% |
| Mr Gary Brian Stone & Mrs Janis Ann Stone | 1,370,000 | 1.01% |
| Mr Philip Bickley Callard | 1,295,684 | 0.96% |
| Mr Joel David Webb | 1,200,000 | 0.89% |
| All other shareholders | 42.57 % | |
The Top 20 Shareholders of MGZ hold 57.43% of shares on issue.
MGZ Share Price History
| Date | Close | Change | % Change | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
MGZ Historical Data
Download up to 20 years of share price history.
| Year | Closing Price (30 June) | Last Trade |
|---|---|---|
| 2020 | $0.02 | 30 June |
| 2019 | $0.02 | 28 June |
| 2018 | $0.016 | 29 June |
| 2017 | $0.011 | 28 June |
| 2016 | $0.038 | 28 June |
| 2015 | $0.075 | 30 June |
| 2014 | $0.023 | 30 June |
Offical data as published by ASX. See more Data Downloads.
Company Details
Principal Activity: Medical technologies innovation and research and development; acquisition of a licence to utilise intellectual property to advance the KT009 project to treat degenerative disk disease with an injectable product; progressing and maintenance of patents and conduct of our licence arrangement and liaison with Shanghai Sol-Millennium Medical Products Co., Ltd on the Blood Collection Device and the Flash Back Needle. The licence was terminated after the end of the financial year.
Incorporated: Medigard Limited was incorporated on 18 October 1999 in Queensland.
-
-
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.